Market closed
Intensity Therapeutics Inc./$INTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Intensity Therapeutics Inc.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
Ticker
$INTS
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
6
ISIN
US45828J1034
INTS Metrics
BasicAdvanced
$8.2M
-
-$1.17
-
-
Price and volume
Market cap
$8.2M
52-week high
$2.50
52-week low
$0.50
Average daily volume
247K
Financial strength
Current ratio
1.916
Quick ratio
1.476
Long term debt to equity
3.77
Total debt to equity
4.729
Management effectiveness
Return on assets (TTM)
-93.90%
Return on equity (TTM)
-202.34%
Valuation
Price to book
2.79
Price to tangible book (TTM)
2.79
Price to free cash flow (TTM)
-0.492
Growth
Earnings per share change (TTM)
-15.03%
3-year earnings per share growth (CAGR)
-20.35%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Intensity Therapeutics Inc. stock?
Intensity Therapeutics Inc. (INTS) has a market cap of $8.2M as of May 14, 2025.
What is the P/E ratio for Intensity Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Intensity Therapeutics Inc. (INTS) stock is 0 as of May 14, 2025.
Does Intensity Therapeutics Inc. stock pay dividends?
No, Intensity Therapeutics Inc. (INTS) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Intensity Therapeutics Inc. dividend payment date?
Intensity Therapeutics Inc. (INTS) stock does not pay dividends to its shareholders.
What is the beta indicator for Intensity Therapeutics Inc.?
Intensity Therapeutics Inc. (INTS) does not currently have a Beta indicator.